Yu J - Search Results

1

EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.

Batova A, Cottam H, Yu J, Diccianni MB, Carrera CJ, Yu AL. Batova A, et al. Among authors: yu al, yu j. Blood. 2006 Feb 1;107(3):898-903. doi: 10.1182/blood-2005-06-2430. Epub 2005 Oct 18. Blood. 2006. PMID: 16234352 Free PMC article.

2

Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.

Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL. Batova A, et al. Among authors: yu al, yu jc. Cancer Res. 1997 Mar 1;57(5):832-6. Cancer Res. 1997. PMID: 9041181

3

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.

Batova A, Shao LE, Diccianni MB, Yu AL, Tanaka T, Rephaeli A, Nudelman A, Yu J. Batova A, et al. Among authors: yu al, yu j. Blood. 2002 Nov 1;100(9):3319-24. doi: 10.1182/blood-2002-02-0567. Blood. 2002. PMID: 12384433 Free article.

4

3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner.

Diccianni MB, Yu J, Meppelink G, de Vries M, Shao L, Gebauer S, Shih H, Roberts W, Kilcoin NP, Pullen J, Carson DA, Yu AL. Diccianni MB, et al. Among authors: yu al, yu j. J Exp Ther Oncol. 2004 Oct;4(3):223-37. J Exp Ther Oncol. 2004. PMID: 15724842

5

c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development.

Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, Yu AL. Lin YC, et al. Among authors: yu al, yu j. Mol Biol Evol. 2008 Oct;25(10):2189-98. doi: 10.1093/molbev/msn165. Epub 2008 Jul 29. Mol Biol Evol. 2008. PMID: 18667440

6

BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug sensitive and drug resistant leukemia cells and solid tumors.

Lee CH, Chou TC, Su TL, Yu J, Shao LE, Yu AL. Lee CH, et al. Among authors: yu al, yu j. Cancer Lett. 2009 Apr 18;276(2):204-11. doi: 10.1016/j.canlet.2008.11.006. Epub 2008 Dec 23. Cancer Lett. 2009. PMID: 19108949

7

The synthetic caged garcinia xanthone cluvenone induces cell stress and apoptosis and has immune modulatory activity.

Batova A, Altomare D, Chantarasriwong O, Ohlsen KL, Creek KE, Lin YC, Messersmith A, Yu AL, Yu J, Theodorakis EA. Batova A, et al. Among authors: yu al, yu j. Mol Cancer Ther. 2010 Nov;9(11):2869-78. doi: 10.1158/1535-7163.MCT-10-0517. Epub 2010 Sep 29. Mol Cancer Ther. 2010. PMID: 20881270 Free PMC article.

8

Surface markers in stem cells and cancer from the perspective of glycomic analysis.

Cho HC, Liao CH, Yu AL, Yu J. Cho HC, et al. Among authors: yu al, yu j. Int J Biol Markers. 2012 Dec 27;27(4):e344-52. doi: 10.5301/JBM.2012.10361. Int J Biol Markers. 2012. PMID: 23250773 Free article.

9

The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.

Chang WW, Lin RJ, Yu J, Chang WY, Fu CH, Lai A, Yu JC, Yu AL. Chang WW, et al. Among authors: yu al, yu jc, yu j. Breast Cancer Res. 2013 May 12;15(3):R39. doi: 10.1186/bcr3423. Breast Cancer Res. 2013. PMID: 23663564 Free PMC article.

10

Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.

Wang SH, Lee AC, Chen IJ, Chang NC, Wu HC, Yu HM, Chang YJ, Lee TW, Yu JC, Yu AL, Yu J. Wang SH, et al. Among authors: yu al, yu jc, yu hm, yu j. Biomaterials. 2016 Jul;94:31-44. doi: 10.1016/j.biomaterials.2016.03.050. Epub 2016 Apr 6. Biomaterials. 2016. PMID: 27088408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,122 results

Search Page

Filters